Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
Dysfunction or dysregulation of the ubiquitin proteasome system (UPS) is closely related to tumorigenesis and the development of multiple cancers. Targeting the UPS provides a new anticancer therapeutic strategy, but clinically available UPS-targeted inhibitors, including lenalidomide and bortezomib...
Saved in:
Main Authors: | Tao Yuan (Author), Fangjie Yan (Author), Meidan Ying (Author), Ji Cao (Author), Qiaojun He (Author), Hong Zhu (Author), Bo Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
by: Yifan Chen, et al.
Published: (2021) -
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
by: Xuankun Chen, et al.
Published: (2022) -
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
by: Lucas Cruz, et al.
Published: (2021) -
Proinflammatory Effects of Ubiquitin-Specific Protease 5 (USP5) in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
by: Xiao-Bo Luo, et al.
Published: (2020) -
The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity
by: Yujia Li, et al.
Published: (2019)